Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT03465618 : A First in Human Study Using 89Zr-cRGDY Ultrasmall Silica Particle Tracers for Malignant Brain Tumors
PhasePhase 1
AgesMin: 18 Years Max: N/A
Eligibility
Inclusion Criteria:

- 18 years of age or older

- Histologically confirmed diagnosis of malignant primary brain tumor or known
metastatic cancer with brain lesion presumed to be metastatic.

- Normal baseline cardiac function based upon pre-operative evaluation at the physcian's
discretion

- All patients of childbearing age must use an acceptable form of birth control

- Women who are pre-menopausal must have a negative serum pregnancy test

Exclusion Criteria:

- Known pregnancy or breast-feeding Medical illness unrelated to the tumor which in the
opinion of the attending physician and principal investigator will preclude
administration of the tracer

°This includes patients with uncontrolled infection, chronic renal insufficiency,
myocardial infarction within the past 6 months, unstable angina, cardiac arrhythmias
other than chronic atrial fibrillation and chronic active or persistent hepatitis, or
New York Heart Association Classification III or IV heart disease

- More than one metastatic cancer active in the last 5 years

- Active metastatic cancer in addition to malignant primary brain tumor

- Weight greater than the 400-lb weight limit of the PET scanner

- Unmanageable Claustrophobia

- Inability to lie in the scanner for 30 minutes
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT03465618      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740